Type: Sources Sought
Product Service Code: 6505 Drugs and Biologics
Place of Performance: HHS BARDA
To: Prospective Partners & Interested Parties
The Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS), is issuing this Request for Information (RFI) to collect feedback from current and potential biopharmaceutical industry partners. Information collected from this RFI will serve as continued market research for the development of a possible program where BARDA would partner with industry to achieve the pandemic preparedness goals set forth by the U.S. Government (USG).
Background: The Department of Health and Human Services (DHHS) is engaging with other Federal agencies and the White House in a whole-of-Government review, update, and transformation of U.S. bio-preparedness capabilities, as outlined in the White House’s September 2021 report, American Pandemic Preparedness: Transforming our Capabilities.1 This effort will fundamentally transform the Nation’s biodefense and pandemic readiness and address challenges experienced during the ongoing COVID-19 pandemic. Work is being organized across five pillars: (I) Transforming our Medical Defenses, (II) Ensuring Situational Awareness, (III) Strengthening Public Health Systems, (IV) Building Core Capabilities, and (V) Managing the Mission.
The subject of this Sources Sought are Goal I: Transforming our Medical Defenses and Goal IV: Building Core Capabilities, as they pertain to BARDA’s ongoing effort to expand the industrial supply chain for medical countermeasure (MCM) production, manufacturing, and implementation.2